- Home
- / BioAegis Therapeutics
BioAegis Therapeutics
Total Funding
$20.3 M
BioAegis Therapeutics Summary
Company Summary
- Overview
- BioAegis Therapeutics is a company focused on developing therapies for infectious, inflammatory, and degenerative diseases. It offers protein replacement therapies based on the endogenous human protein, plasma gelsolin (pGSN).
- Type
- Private
- Status
- Active
- Founded
- 2011
- Cybersecurity rating
Table of Contents
Key People
Susan L. Levinson, Chief Executive Officer
Valerie Ceva, Chief Operating Officer
Mark J. DiNubile, Chief Medical Officer